Alberta NINT/17 June 2008

From 2008.igem.org

(Difference between revisions)
(New page: lab work (SD): Transformed XL1-B cells with: K102000 + I732018.1 K102000 + I732018.2 K102000 (negative control))
Line 4: Line 4:
                   K102000 + I732018.2
                   K102000 + I732018.2
                   K102000 (negative control)
                   K102000 (negative control)
 +
 +
lab work (JD):
 +
              Re-created K102003 with new LacZ parts I732018.1 and I732018.2
 +
              Ligated K102001 with LacZ Parts
 +
              Transformed and plated XL1-B cells with K102003(1) (containing LacZ part I732018.1) and K102003(2) (containing LacZ part I732018.2)
 +
              Our plates of K102007 from yesterday with 1/10 1/100 and 1/1000 dilutions didn't seem to make any difference so we are going to recut TA0
 +
              Restriction digest of TA0 with BamH1 and Nco1
 +
              Nucleotide removal of TA0/B+N
 +
              Created glycerol stock of K102005
 +
              Made fresh O/N of K102005 to be used tomorrow

Revision as of 19:46, 19 June 2008

lab work (SD):

            Transformed XL1-B cells with:
                 K102000 + I732018.1
                 K102000 + I732018.2
                 K102000 (negative control)

lab work (JD):

              Re-created K102003 with new LacZ parts I732018.1 and I732018.2
              Ligated K102001 with LacZ Parts
              Transformed and plated XL1-B cells with K102003(1) (containing LacZ part I732018.1) and K102003(2) (containing LacZ part I732018.2)
              Our plates of K102007 from yesterday with 1/10 1/100 and 1/1000 dilutions didn't seem to make any difference so we are going to recut TA0
              Restriction digest of TA0 with BamH1 and Nco1
              Nucleotide removal of TA0/B+N
              Created glycerol stock of K102005
              Made fresh O/N of K102005 to be used tomorrow